AI generated summary of Pubmed citation/abstract with PMID 38093160

https://pubmed.ncbi.nlm.nih.gov/38093160

Zilucoplan was approved in Japan, the USA, and the EU in 2023 for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive.